Synthomer (SYNT) Competitors GBX 96.90 -5.50 (-5.37%) As of 07:45 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock SYNT vs. VCT, SCPA, ESNT, TET, ZTF, IOF, WCH, ITX, DCTA, and HDDShould you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry. Synthomer vs. Victrex Scapa Group Essentra Treatt Zotefoams Iofina Wilmcote Holdings plc (WCH.L) Itaconix Directa Plus Hardide Synthomer (LON:SYNT) and Victrex (LON:VCT) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, community ranking, institutional ownership, earnings, valuation and profitability. Which has more risk and volatility, SYNT or VCT? Synthomer has a beta of 1.79, meaning that its stock price is 79% more volatile than the S&P 500. Comparatively, Victrex has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Is SYNT or VCT a better dividend stock? Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 24.4%. Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 7.4%. Synthomer pays out -50.1% of its earnings in the form of a dividend. Victrex pays out 170.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has higher valuation and earnings, SYNT or VCT? Victrex has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynthomer£1.87B0.09-£82.04M-£49.90-2.05Victrex£285.02M2.47£30.80M£35.2022.93 Does the media favor SYNT or VCT? In the previous week, Victrex had 3 more articles in the media than Synthomer. MarketBeat recorded 3 mentions for Victrex and 0 mentions for Synthomer. Victrex's average media sentiment score of 1.30 beat Synthomer's score of -0.55 indicating that Victrex is being referred to more favorably in the news media. Company Overall Sentiment Synthomer Negative Victrex Positive Do analysts recommend SYNT or VCT? Synthomer presently has a consensus target price of GBX 225, suggesting a potential upside of 119.94%. Victrex has a consensus target price of GBX 1,170, suggesting a potential upside of 44.98%. Given Synthomer's stronger consensus rating and higher possible upside, equities analysts plainly believe Synthomer is more favorable than Victrex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synthomer 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Victrex 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals have more ownership in SYNT or VCT? 43.8% of Synthomer shares are held by institutional investors. Comparatively, 97.1% of Victrex shares are held by institutional investors. 28.0% of Synthomer shares are held by company insiders. Comparatively, 1.6% of Victrex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer SYNT or VCT? Synthomer received 220 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.46% of users gave Synthomer an outperform vote while only 63.61% of users gave Victrex an outperform vote. CompanyUnderperformOutperformSynthomerOutperform Votes72768.46% Underperform Votes33531.54% VictrexOutperform Votes50763.61% Underperform Votes29036.39% Is SYNT or VCT more profitable? Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.40%. Victrex's return on equity of 6.67% beat Synthomer's return on equity.Company Net Margins Return on Equity Return on Assets Synthomer-4.40% -7.52% -0.28% Victrex 10.81%6.67%6.59% SummarySynthomer and Victrex tied by winning 10 of the 20 factors compared between the two stocks. Get Synthomer News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYNT vs. The Competition Export to ExcelMetricSynthomerSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£167.75M£8.26B£3.10B£2.68BDividend Yield28.47%3.58%5.08%4.96%P/E Ratio-2.0513.2574.34138.25Price / Sales0.0950.4626,914,679,906,498,300.00211,784.56Price / Cash2.2819.2524.3628.02Price / Book0.154.725.213.80Net Income-£82.04M£220.83M£154.55M£5.88B7 Day Performance-9.11%1.26%0.64%15.14%1 Month Performance26.14%7.32%4.46%29.40%1 Year Performance-69.37%-18.66%22.72%121.07% Synthomer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYNTSynthomer2.1528 of 5 starsGBX 96.90-5.4%GBX 225+132.2%-69.4%£158.89M£1.87B-1.944,200Gap DownVCTVictrex3.261 of 5 starsGBX 843.41+0.0%GBX 1,170+38.7%-40.2%£735.72M£285.02M23.961,109Positive NewsDividend IncreaseSCPAScapa GroupN/AN/AN/AN/A£402.98M£281.80M-7.321,461ESNTEssentra1.7206 of 5 starsGBX 99.13+0.4%GBX 206.67+108.5%-45.7%£284.93M£309.74M81.66350News CoverageTETTreatt2.9143 of 5 starsGBX 271.25-0.1%GBX 650+139.6%-47.6%£164.00M£142.31M14.66350News CoveragePositive NewsDividend IncreaseGap UpZTFZotefoamsN/AGBX 254flatN/A-47.9%£122.17M£131.66M12.30549IOFIofina2.0872 of 5 starsGBX 23.12-1.6%GBX 36.25+56.8%+10.8%£55.51M£61.34M16.2395WCHWilmcote Holdings plc (WCH.L)N/AN/AN/AN/A£20.13MN/A-5.003ITXItaconixN/AGBX 110+4.8%N/A-37.7%£14.84M£5.28M-9.9617Gap DownDCTADirecta PlusN/AGBX 7+0.7%N/A-67.8%£9.42M£20.29M-1.25187HDDHardideN/AGBX 7.18+2.7%N/A+15.2%£5.66M£6.11M-3.0046Earnings Report Related Companies and Tools Related Companies Victrex Alternatives Scapa Group Alternatives Essentra Alternatives Treatt Alternatives Zotefoams Alternatives Iofina Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Itaconix Alternatives Directa Plus Alternatives Hardide Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SYNT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthomer plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synthomer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.